abs92.txt	uterine	serous	carcinoma	(usc)	represents	an	aggressive	histologic	subtype	ofendometrial	cancer		it	is	associated	with	a	poor	prognosis	and	improvedtherapies	for	women	battling	uscs	are	greatly	needed	onc201	orallybioavailable	first-in-class	small	molecule	that	induces	tumor	necrosisfactor-related	apoptosis-inducing	ligand	(trail)	independent	of	p53	hasdemonstrated	anti-tumorigenic	activity	in	pre-clinical	models	solid	tumorsthrough	induction	apoptosis	inactivation	the	akt/mapk	pathways	recentphase	i	ii	clinical	trials	have	shown	well	tolerated	mayhave	single	agent	high	grade	glioma	patients	among	others	we	soughtto	determine	effects	on	cell	proliferation	usc	identify	themechanisms	by	which	inhibits	growth	this	disease	inhibitedcell	dose-dependent	manner	ark1	ark2	spec-2	celllines	anti-proliferative	cells	wasassociated	via	both	trail	mediatedapoptotic	pathway	mitochondrial	treatment	onc201resulted	significant	reduction	adhesion	invasion	as	inhibitionof	akt	mapk	addition	markedly	potentiated	theanti-tumorigenic	paclitaxel	our	results	suggest	thatonc201	has	anti-metastatic	usccells	through	inhibition	mapkpathways	promising	therapeutic	combination	thus	should	be	evaluated	therapeuticpartner	future
